A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models

Oncolytic viruses have shown excellent safety profiles in preclinical and clinical studies; however, in most cases therapeutic benefits have been modest. We have previously reported the generation of a chimeric poxvirus (CF33), with significantly improved oncolytic characteristics, through chimeriza...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Gene Ther
Main Authors: Chaurasiya, Shyambabu, Chen, Nanhai G., Lu, Jianming, Martin, Nikolas, Shen, Yinan, Kim, Sang-In, Warner, Susanne G., Woo, Yanghee, Fong, Yuman
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group US 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170804/
https://ncbi.nlm.nih.gov/pubmed/31209267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-019-0114-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares